Microbix Biosystems Inc
TSX:MBX
Balance Sheet
Balance Sheet Decomposition
Microbix Biosystems Inc
Microbix Biosystems Inc
Balance Sheet
Microbix Biosystems Inc
| Sep-2002 | Sep-2003 | Sep-2004 | Sep-2005 | Sep-2006 | Sep-2007 | Sep-2008 | Sep-2009 | Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
1
|
1
|
1
|
1
|
0
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
13
|
12
|
13
|
12
|
|
| Cash |
1
|
1
|
1
|
1
|
0
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
13
|
12
|
13
|
12
|
|
| Total Receivables |
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
4
|
3
|
4
|
4
|
2
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
4
|
3
|
4
|
4
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
6
|
6
|
9
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
2
|
2
|
2
|
2
|
2
|
6
|
3
|
3
|
3
|
3
|
3
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
19
|
22
|
22
|
24
|
24
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
2
|
2
|
5
|
7
|
7
|
6
|
6
|
6
|
9
|
12
|
12
|
12
|
7
|
7
|
7
|
8
|
9
|
9
|
10
|
10
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
2
|
2
|
5
|
7
|
7
|
6
|
6
|
6
|
9
|
12
|
0
|
0
|
0
|
0
|
7
|
8
|
9
|
9
|
10
|
10
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
3
|
4
|
4
|
0
|
0
|
0
|
0
|
6
|
7
|
7
|
8
|
10
|
11
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
6
|
6
|
5
|
5
|
2
|
2
|
2
|
4
|
4
|
4
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
3
+10%
|
3
+14%
|
4
+16%
|
4
+0%
|
6
+46%
|
15
+152%
|
14
-3%
|
14
+2%
|
14
-3%
|
14
-2%
|
13
-6%
|
18
+42%
|
24
+31%
|
25
+7%
|
26
+5%
|
19
-27%
|
20
+2%
|
16
-21%
|
29
+85%
|
33
+15%
|
36
+8%
|
38
+7%
|
37
-2%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
1
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
2
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
1
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
1
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
2
|
3
|
4
|
5
|
7
|
4
|
5
|
4
|
5
|
3
|
4
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
2
|
4
|
5
|
6
|
6
|
6
|
5
|
5
|
6
|
5
|
5
|
5
|
4
|
5
|
5
|
6
|
6
|
6
|
7
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+65%
|
1
+12%
|
1
+6%
|
2
+110%
|
4
+42%
|
7
+98%
|
8
+10%
|
9
+13%
|
9
+4%
|
9
+4%
|
7
-26%
|
8
+17%
|
10
+21%
|
10
+1%
|
11
+13%
|
9
-20%
|
9
+1%
|
9
-1%
|
10
+14%
|
8
-20%
|
11
+34%
|
10
-11%
|
10
-2%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
9
|
9
|
9
|
9
|
9
|
12
|
19
|
19
|
21
|
22
|
24
|
24
|
28
|
31
|
31
|
31
|
34
|
34
|
35
|
44
|
50
|
49
|
49
|
50
|
|
| Retained Earnings |
6
|
7
|
7
|
7
|
9
|
12
|
16
|
18
|
21
|
23
|
26
|
25
|
25
|
24
|
23
|
27
|
36
|
36
|
42
|
39
|
37
|
37
|
33
|
36
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
3
|
4
|
4
|
4
|
5
|
8
|
9
|
9
|
10
|
11
|
10
|
10
|
11
|
11
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Total Equity |
2
N/A
|
2
-6%
|
2
+15%
|
3
+21%
|
1
-47%
|
2
+54%
|
8
+234%
|
6
-16%
|
6
-12%
|
5
-16%
|
4
-14%
|
6
+39%
|
10
+72%
|
14
+39%
|
15
+12%
|
15
-1%
|
10
-32%
|
11
+2%
|
7
-37%
|
19
+180%
|
25
+34%
|
25
-1%
|
28
+15%
|
28
-2%
|
|
| Total Liabilities & Equity |
3
N/A
|
3
+10%
|
3
+14%
|
4
+16%
|
4
+0%
|
6
+46%
|
15
+152%
|
14
-4%
|
14
+2%
|
14
-3%
|
14
-2%
|
13
-6%
|
18
+42%
|
24
+31%
|
25
+7%
|
26
+5%
|
19
-27%
|
20
+2%
|
16
-21%
|
29
+85%
|
33
+15%
|
36
+8%
|
38
+7%
|
37
-2%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
34
|
35
|
35
|
35
|
35
|
39
|
46
|
48
|
52
|
58
|
66
|
67
|
76
|
83
|
85
|
85
|
97
|
97
|
109
|
126
|
139
|
137
|
136
|
140
|
|